Bull
$128.92
情境價格
$116.520
-0.058 (-0.05%)收盤時
Aflac Incorporated provides financial protection to policyholders and customers through its subsidiaries in the United States and Japan. The Company's principal business is supplemental health and life insurance products. Its segments include Aflac Japan, which includes Aflac Life Insurance Japan Ltd. (ALIJ), and Aflac U.S., which includes American Family Life Assurance Company of Columbus (Aflac), American Family Life Assurance Company of New York (Aflac New York), Continental American Insurance Company (CAIC), Tier One Insurance Company (TOIC), and Aflac Benefits Solutions, Inc. (ABS). The Aflac Japan segment is the insurer in Japan in terms of cancer and medical (third sector insurance products) policies in force. The Company designs its United States insurance products to provide supplemental coverage for people who already have major medical or primary insurance coverage, as Aflac U.S. insurance policies pay benefits regardless of other insurance.
Aflac Inc is currently priced at $116.52, with a forward P/E of 14.53, which is relatively low compared to the market average. However, the RSI is at 35.76, indicating that the stock is in the oversold territory, suggesting potential for a rebound. The main risk is the 6.9% year-over-year decline in Q2 sales, which reflects challenges in the Japanese market and could impact future growth. Overall, while there are some positive indicators, the current sales decline and mixed analyst ratings suggest holding rather than buying.
Wells Fargo
$122
2026-08-19
Wells Fargo
2026-08-19
目標價
$122
Wolfe Research
$103
2026-08-19
Wolfe Research
2026-08-19
目標價
$103
JPMorgan
$116
2026-08-11
JPMorgan
2026-08-11
目標價
$116
Keefe Bruyette
$125
2026-08-11
Keefe Bruyette
2026-08-11
目標價
$125
Mizuho
$116
2026-08-10
Mizuho
2026-08-10
目標價
$116
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Aflac's Q2 Earnings Call Reveals Key Insights

Monitoring Oil Prices and Bond Market Dynamics

Aflac Launches Reading Initiative 'Beyond Words'

Aflac Reports Strong Q2 2026 Earnings with Strategic Growth Initiatives

AFLAC to Host Q2 2026 Earnings Call on August 7
Aflac Incorporated provides financial protection to policyholders and customers through its subsidiaries in the United States and Japan. The Company's principal business is supplemental health and life insurance products. Its segments include Aflac Japan, which includes Aflac Life Insurance Japan Ltd. (ALIJ), and Aflac U.S., which includes American Family Life Assurance Company of Columbus (Aflac), American Family Life Assurance Company of New York (Aflac New York), Continental American Insurance Company (CAIC), Tier One Insurance Company (TOIC), and Aflac Benefits Solutions, Inc. (ABS). The Aflac Japan segment is the insurer in Japan in terms of cancer and medical (third sector insurance products) policies in force. The Company designs its United States insurance products to provide supplemental coverage for people who already have major medical or primary insurance coverage, as Aflac U.S. insurance policies pay benefits regardless of other insurance. It operates in the Financials sector (ACCIDENT & HEALTH INSURANCE industry).
Aflac Inc is currently priced at $116.52, with a forward P/E of 14.53, which is relatively low compared to the market average. However, the RSI is at 35.76, indicating that the stock is in the oversold territory, suggesting potential for a rebound. The main risk is the 6.9% year-over-year decline in Q2 sales, which reflects challenges in the Japanese market and could impact future growth. Overall, while there are some positive indicators, the current sales decline and mixed analyst ratings suggest holding rather than buying.
15 analysts cover AFL: 3 rate it Buy, 10 Hold and 2 Sell. The average price target is 110.90.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。